Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacobus R B J Brouwers

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Pharmacy World & Science : PWS|May 3, 2005
Pharmacogenetics as a tool in the therapy of schizophreniaBob Wilffert, Rianne Zaal, Jacobus R B J Brouwers
Scientifica|November 27, 2013
Clinical pharmacology in old personsPaul A F Jansen, Jacobus R B J Brouwers
Thrombosis and Haemostasis|January 10, 2009
Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumonMaarten Beinema, Jacobus R B J Brouwers, Tom Schalekamp, et al.
The Annals of Pharmacotherapy|October 13, 2005
Thalidomide-associated thrombocytopeniaMichiel Duyvendak, Mark Naunton, Bert J Kingma, et al.
Pharmacoeconomics|July 6, 2007
Cost considerations in the treatment of colorectal cancerFrank G A Jansman, Maarten J Postma, Jacobus R B J Brouwers
British Journal of Clinical Pharmacology|August 6, 2019
Biosimilars of low molecular weight heparins: Relevant background information for your drug formularyJacobus R B J Brouwers, Jeanine E Roeters van Lennep, Maarten J Beinema
Journal of Medical Economics|May 9, 2012
Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the NetherlandsMaarten J Postma, Bregt S Kappelhoff, Marinus van Hulst, et al.
Vaccine|December 17, 2008
Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for healthRobin de Vries, Rogier M Klok, Jacobus R B J Brouwers, et al.
British Journal of Clinical Pharmacology|January 17, 2012
Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic reviewMarlies M E Geurts, Jaap Talsma, Jacobus R B J Brouwers, et al.
International Journal of Clinical Pharmacy|January 4, 2013
Characteristics of potential drug-related problems among oncology patientsArjan Bulsink, Alex L T Imholz, Jacobus R B J Brouwers, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Pharmacy World & Science : PWS|May 3, 2005
Pharmacogenetics as a tool in the therapy of schizophreniaBob Wilffert, Rianne Zaal, Jacobus R B J Brouwers
Scientifica|November 27, 2013
Clinical pharmacology in old personsPaul A F Jansen, Jacobus R B J Brouwers
Thrombosis and Haemostasis|January 10, 2009
Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumonMaarten Beinema, Jacobus R B J Brouwers, Tom Schalekamp, et al.
The Annals of Pharmacotherapy|October 13, 2005
Thalidomide-associated thrombocytopeniaMichiel Duyvendak, Mark Naunton, Bert J Kingma, et al.
Pharmacoeconomics|July 6, 2007
Cost considerations in the treatment of colorectal cancerFrank G A Jansman, Maarten J Postma, Jacobus R B J Brouwers
British Journal of Clinical Pharmacology|August 6, 2019
Biosimilars of low molecular weight heparins: Relevant background information for your drug formularyJacobus R B J Brouwers, Jeanine E Roeters van Lennep, Maarten J Beinema
Journal of Medical Economics|May 9, 2012
Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the NetherlandsMaarten J Postma, Bregt S Kappelhoff, Marinus van Hulst, et al.
Vaccine|December 17, 2008
Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for healthRobin de Vries, Rogier M Klok, Jacobus R B J Brouwers, et al.
British Journal of Clinical Pharmacology|January 17, 2012
Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic reviewMarlies M E Geurts, Jaap Talsma, Jacobus R B J Brouwers, et al.
International Journal of Clinical Pharmacy|January 4, 2013
Characteristics of potential drug-related problems among oncology patientsArjan Bulsink, Alex L T Imholz, Jacobus R B J Brouwers, et al.
Pageof 7